29th March 2020 Neurolytic Healthcare

The COVID-19 crisis has highlighted the importance of remote medical treatment options that can be accessed from home. As overburdened healthcare systems focus their resources to manage the crisis, inevitably healthcare provisions for other conditions decrease. Even after the current pandemic, healthcare providers worldwide will continue to struggle with resource limitations – unless we embrace fundamentally new options of providing high quality healthcare remotely. 

Latest advances in molecular biology, digital sensor technology and artificial intelligence allow for diagnostics, prescription and disease management to be conducted safely and reliably from home – and help save millions of lives. We are continuing our work that aims to help migraine patients and reduce the burden on strained healthcare systems all over the world.